{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T04:24:14Z","timestamp":1772598254054,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.ajpath.2013.01.023","type":"journal-article","created":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T10:38:55Z","timestamp":1362479935000},"page":"1640-1647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Interaction between CX3CL1 and CX3CR1 Regulates Vasculitis Induced by Immune Complex Deposition"],"prefix":"10.1016","volume":"182","author":[{"given":"Sohshi","family":"Morimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Sugaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2013.01.023_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1074-7613(00)80583-X","article-title":"Chemokines and T lymphocytes: more than an attraction","volume":"9","author":"Ward","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.ajpath.2013.01.023_bib2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199802123380706","article-title":"Chemokines: chemotactic cytokines that mediate inflammation","volume":"338","author":"Luster","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2013.01.023_bib3","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1146\/annurev.immunol.15.1.675","article-title":"Human chemokines: an update","volume":"15","author":"Baggiolini","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ajpath.2013.01.023_bib4","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.4049\/jimmunol.156.10.3583","article-title":"\u201cThe good, the bad, and the ugly\u201d: the role of chemokines in models of human disease","volume":"156","author":"Strieter","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2013.01.023_bib5","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1182\/blood.V90.3.909","article-title":"Chemokines","volume":"90","author":"Rollins","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2013.01.023_bib6","first-page":"451","article-title":"Chemokine receptors: future therapeutic targets for HIV?","volume":"57","author":"Proudfoot","year":"1999","journal-title":"Brioche Pharmacol"},{"key":"10.1016\/j.ajpath.2013.01.023_bib7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1189\/jlb.69.4.513","article-title":"Chemokines in cutaneous wound healing","volume":"69","author":"Gillitzer","year":"2001","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.ajpath.2013.01.023_bib8","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1172\/JCI115385","article-title":"Augmentation of reverse Arthus reaction by mast cells in mice","volume":"88","author":"Zhang","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2013.01.023_bib9","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/385640a0","article-title":"A new class of membrane-bound chemokine with a CX3C motif","volume":"385","author":"Bazan","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2013.01.023_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1615\/CritRevImmunol.v24.i3.40","article-title":"C and CX3C chemokines: cell sources and physiopathological implications","volume":"24","author":"Stievano","year":"2004","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.ajpath.2013.01.023_bib11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0092-8674(00)80438-9","article-title":"Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion","volume":"91","author":"Imai","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2013.01.023_bib12","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1161\/CIRCRESAHA.107.160812","article-title":"Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells through CX3CR1 and the Jak Stat5 pathway","volume":"101","author":"Yang","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpath.2013.01.023_bib13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0923-1811(03)00031-8","article-title":"Human keratinocytes express fractalkine\/CX3CL1","volume":"31","author":"Sugaya","year":"2003","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.ajpath.2013.01.023_bib14","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0161-5890(99)00111-X","article-title":"On the role of complement and Fc gamma-receptors in the Arthus reaction","volume":"36","author":"Kohl","year":"1999","journal-title":"Mol Immunol"},{"key":"10.1016\/j.ajpath.2013.01.023_bib15","first-page":"817","article-title":"Injections repetees de serum de cheval chez le lapin","volume":"55","author":"Arthus","year":"1903","journal-title":"V R Soc Biol"},{"key":"10.1016\/j.ajpath.2013.01.023_bib16","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.4049\/jimmunol.164.2.1065","article-title":"A codominant role of Fc gamma RI\/III and C5aR in the reverse Arthus reaction","volume":"164","author":"Baumann","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2013.01.023_bib17","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1084\/jem.186.5.749","article-title":"Impaired inflammatory responses in the reverse Arthus reaction through genetic deletion of the C5a receptor","volume":"186","author":"Hopken","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2013.01.023_bib18","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1126\/science.8066448","article-title":"Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade","volume":"265","author":"Sylvestre","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2013.01.023_bib19","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.167.2.1022","article-title":"Distinct tissue site-specific requirements of mast cells and complement components C3\/C5a receptor in IgG immune complex-induced injury of skin and lung","volume":"167","author":"Baumann","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2013.01.023_bib20","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.4049\/jimmunol.168.6.2970","article-title":"The cutaneous reverse Arthus reaction requires intercellular adhesion molecule 1 and L-selectin expression","volume":"168","author":"Kaburagi","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2013.01.023_bib21","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1152\/physrev.2003.83.3.835","article-title":"Regulation of wound healing by growth factors and cytokines","volume":"83","author":"Werner","year":"2003","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ajpath.2013.01.023_bib22","doi-asserted-by":"crossref","first-page":"569","DOI":"10.4049\/jimmunol.180.1.569","article-title":"Chemokine receptor CX3CR1 mediates skin wound healing by prompting macrophage and fibroblast accumulation and function","volume":"180","author":"Ishida","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2013.01.023_bib23","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1096\/fj.05-5465com","article-title":"The neuronal chemokine CX3CL1\/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system","volume":"20","author":"Huang","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.ajpath.2013.01.023_bib24","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ijc.22660","article-title":"Defective antitumor responses in CX3CR1-deficient mice","volume":"121","author":"Yu","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2013.01.023_bib25","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1128\/MCB.21.9.3159-3165.2001","article-title":"Generation and analysis of mice lacking the chemokine fractalkine","volume":"21","author":"Cook","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ajpath.2013.01.023_bib26","first-page":"72","article-title":"Elevated serum levels of soluble CX3CL1 in patients with microscopic polyangiitis","volume":"27","author":"Matsunawa","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ajpath.2013.01.023_bib27","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/art.21042","article-title":"Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations","volume":"52","author":"Yajima","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajpath.2013.01.023_bib28","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3899\/jrheum.081074","article-title":"Correlation of CX3CL1 and CX3CR1 levels with response to infliximab therapy in patients with rheumatoid arthritis","volume":"36","author":"Odai","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ajpath.2013.01.023_bib29","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1161\/01.CIR.0000057548.68243.42","article-title":"Decreased atherosclerotic lesion formation in CX3CR1\/apolipoprotein E double knockout mice","volume":"107","author":"Combadiere","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ajpath.2013.01.023_bib30","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1054-8807(02)00111-4","article-title":"Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease","volume":"11","author":"Wong","year":"2002","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.ajpath.2013.01.023_bib31","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0002-9440(10)63725-X","article-title":"Tumor necrosis factor-alpha induces fractalkine expression preferentially in arterial endothelial cells and mithramycin A suppresses TNF-alpha-induced fractalkine expression","volume":"164","author":"Ahn","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2013.01.023_bib32","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0002-9440(10)64279-4","article-title":"Relative contributions of selectins and intercellular adhesion molecule-1 to tissue injury induced by immune complex deposition","volume":"162","author":"Yanaba","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2013.01.023_bib33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev.iy.10.040192.002211","article-title":"The pathophysiology of tumor necrosis factors","volume":"10","author":"Vassalli","year":"1992","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ajpath.2013.01.023_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60532-5","article-title":"Interleukin-6 in biology and medicine","volume":"54","author":"Akira","year":"1993","journal-title":"Adv Immunol"},{"key":"10.1016\/j.ajpath.2013.01.023_bib35","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s11926-004-0067-3","article-title":"Endothelial cells, antineutrophil cytoplasmic antibodies, and cytokines in the pathogenesis of systemic vasculitis","volume":"6","author":"Cid","year":"2004","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.ajpath.2013.01.023_bib36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.bor.0000149084.16639.b0","article-title":"Endothelial cell dysfunction in systemic vasculitis: new developments and therapeutic prospects","volume":"17","author":"Bacon","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ajpath.2013.01.023_bib37","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1182\/blood-2011-02-335471","article-title":"The CX3C chemokine fractalkine mediates platelet adhesion via the von Willebrand receptor glycoprotein Ib","volume":"117","author":"Mayer dos Snatos","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2013.01.023_bib38","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/01.ATV.0000095360.62479.1F","article-title":"Fractalkine in vascular biology: from basic research to clinical disease","volume":"24","author":"Umehara","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpath.2013.01.023_bib39","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/art.21007","article-title":"Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL\/lpr mice","volume":"52","author":"Inoue","year":"2005","journal-title":"Arthritis Rheum"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944013001077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944013001077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:41:54Z","timestamp":1757601714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944013001077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0002944013001077"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2013.01.023","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interaction between CX3CL1 and CX3CR1 Regulates Vasculitis Induced by Immune Complex Deposition","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2013.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}